Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

TOMÍŠKOVÁ Marcela SKŘIČKOVÁ Jana VAŠUTOVÁ Irena

Year of publication 2008
Type Article in Periodical
Magazine / Source Journal of Thoracic Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords non-small cell lung cancer; advanced cancer; treatmetment; erlotinib
Description A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC).
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info